These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37727346)

  • 21. Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade.
    Manning AM; Yang H; Falciglia M; Mark JR; Steward DL
    Otolaryngol Head Neck Surg; 2017 Apr; 156(4):611-615. PubMed ID: 28118554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses.
    Rossi M; Lupo S; Rossi R; Franceschetti P; Trasforini G; Bruni S; Tagliati F; Buratto M; Lanza G; Damiani L; Degli Uberti E; Zatelli MC
    Endocrine; 2017 Jul; 57(1):98-107. PubMed ID: 27623969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Underestimated risk of cancer in solitary thyroid nodules ≥3 cm reported as benign.
    Bakkar S; Poma AM; Corsini C; Miccoli M; Ambrosini CE; Miccoli P
    Langenbecks Arch Surg; 2017 Nov; 402(7):1089-1094. PubMed ID: 28689321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology.
    Macias CA; Arumugam D; Arlow RL; Eng OS; Lu SE; Javidian P; Davidov T; Trooskin SZ
    Ann Surg Oncol; 2015 May; 22(5):1527-32. PubMed ID: 25388058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma.
    Mihai R; Parker AJ; Roskell D; Sadler GP
    Thyroid; 2009 Jan; 19(1):33-7. PubMed ID: 18976164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The McGill Thyroid Nodule Score's (MTNS+) role in the investigation of thyroid nodules with benign ultrasound guided fine needle aspiration biopsies: a retrospective review.
    Khalife S; Bouhabel S; Forest VI; Hier MP; Rochon L; Tamilia M; Payne RJ
    J Otolaryngol Head Neck Surg; 2016 May; 45(1):29. PubMed ID: 27142264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeat Fine Needle Aspiration Cytology Refines the Selection of Thyroid Nodules for Afirma Gene Expression Classifier Testing.
    Nishino M; Mateo R; Kilim H; Feldman A; Elliott A; Shen C; Hasselgren PO; Wang H; Hartzband P; Hennessey JV
    Thyroid; 2021 Aug; 31(8):1253-1263. PubMed ID: 33813868
    [No Abstract]   [Full Text] [Related]  

  • 28. Suspicious thyroid nodules 4 cm require a diagnostic lobectomy regardless of their benign fine needle aspiration results.
    Kim HK; Kim SY; Lee YS; Soh EY; Chang HS; Park CS
    Asian J Surg; 2022 May; 45(5):1113-1116. PubMed ID: 34511361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examining the Bethesda criteria risk stratification of thyroid nodules.
    Deniwar A; Hambleton C; Thethi T; Moroz K; Kandil E
    Pathol Res Pract; 2015 May; 211(5):345-8. PubMed ID: 25796296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Malignancy Risk and Its Predictors in South Indian Patients With Bethesda II Thyroid Nodules.
    Tirupati S; Puthenveetil P; Lakkundi S; Gaddam A; Sarathi V
    Cureus; 2024 Feb; 16(2):e54923. PubMed ID: 38544601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
    Kiernan CM; Solórzano CC
    J Am Coll Surg; 2017 Jul; 225(1):77-82. PubMed ID: 28223197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors stratifying malignancy of nodules in contralateral thyroid lobe in patients with pre-operative ultrasound indicated unilateral papillary thyroid carcinoma: A retrospective analysis from single centre.
    Lv T; Zhu C; Di Z
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):279-284. PubMed ID: 29083503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features reclassification and its impact on thyroid malignancy rate and treatment.
    Mao ML; Joyal T; Picado O; Kerr D; Lew JI; Farrá JC
    J Surg Res; 2018 Oct; 230():47-52. PubMed ID: 30100039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unnecessary thyroid surgery rate for suspicious nodule in the absence of molecular testing.
    Mavromati M; Saiji E; Demarchi MS; Lenoir V; Seipel A; Kuczma P; Jornayvaz FR; Becker M; Fernandez E; De Vito C; Triponez F; Leboulleux S
    Eur Thyroid J; 2023 Dec; 12(6):. PubMed ID: 37855426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indeterminate Thyroid Fine-Needle Aspirations in Pediatrics: Exploring Clinicopathologic Features and Utility of Molecular Profiling.
    Baran JA; Halada S; Bauer AJ; Ricarte-Filho JC; Isaza A; Surrey LF; McGrath C; Bhatti T; Jalaly J; Mostoufi-Moab S; Franco AT; Adzick NS; Kazahaya K; Cahill AM; Baloch Z
    Horm Res Paediatr; 2022; 95(5):430-441. PubMed ID: 35871517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Stratification of Thyroid Nodules with Bethesda III Category: The Experience of a Territorial Healthcare Hospital.
    Al Dawish M; Alwin Robert A; Al Shehri K; Hawsawi S; Mujammami M; Al Basha IA; Alrasheed M; Asiri S; Alzouman M; Alkharashi E
    Cureus; 2020 May; 12(5):e8202. PubMed ID: 32455091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of patient characteristics, ultrasound features, and molecular testing with malignancy risk in Bethesda III-V thyroid nodules.
    Talmor G; Badash I; Zhou S; Kim YJ; Kokot NC; Hsueh W; Chambers T
    Laryngoscope Investig Otolaryngol; 2022 Aug; 7(4):1243-1250. PubMed ID: 36000058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignancy rates in thyroid nodules classified as Bethesda categories III and IV; a subcontinent perspective.
    Zahid A; Shafiq W; Nasir KS; Loya A; Abbas Raza S; Sohail S; Azmat U
    J Clin Transl Endocrinol; 2021 Mar; 23():100250. PubMed ID: 33643850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy of the 'CUT' Score for Assessing Malignancy in Bethesda 3 and 4 Thyroid Nodules in North American Population: A Retrospective Study.
    Shihabi AN; Hussein M; Toraih EA; Attia AS; Youssef MR; Elnahla A; Omar M; Shama M; Corsetti R; Kandil E
    Cancer Invest; 2022 Sep; 40(8):693-699. PubMed ID: 35549502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive central lymph-nodes are underdiagnosed in patients with Bethesda V cytology in an endemic goiter region.
    Hargitai L; Strobl S; Koperek O; Urach S; Raber W; Staudenherz A; Scheuba C; Riss P
    Gland Surg; 2020 Apr; 9(2):252-260. PubMed ID: 32420249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.